PIVEKIMAB SUNIRINE
M25-692
Phase 1 small_molecule active
Quick answer
PIVEKIMAB SUNIRINE for Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloid Leukemia, Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie Deutschland GmbH & Co. KG
- Indication
- Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloid Leukemia, Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active